AARTI DRUGS LTD (India) holds 6 active US FDA Type II Drug Master Files and 11 inactive, has DMF or CEP filings on record for 20 active ingredients and is linked to 2 FDA-registered manufacturing sites. 2 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “AARTI DRUGS LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aarti-drugs-ltd

Overview

AARTI DRUGS LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering CELECOXIB; CIPROFLOXACIN HYDROCHLORIDE; NIACIN; RALOXIFENE HYDROCHLORIDE USP; RIVASTIGMINE HYDROGEN TARTRATE; ZOLPIDEM TARTRATE.

Core services & business areas

Pharmaceutical ManufacturingResearch and DevelopmentQuality Control

Active ingredients with DMF or CEP filings

Substances for which AARTI DRUGS LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

AARTI DRUGS LTD holds 6 active (17 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • CELECOXIBActive2009-10-09
  • RIVASTIGMINE HYDROGEN TARTRATEActive2009-07-31
  • RALOXIFENE HYDROCHLORIDE USPActive2008-05-22
  • NIACINActive2006-12-14
  • CIPROFLOXACIN HYDROCHLORIDEActive2006-07-17
  • ZOLPIDEM TARTRATEActive2006-05-16
  • ROFECOXIBInactive2015-09-29
  • PIOGLITAZONE HYDROCHLORIDEInactive2012-07-03
  • DICLOFENAC EPOLAMINEInactive2012-04-03
  • S (-) RIVASTIGMINE BASEInactive2009-04-01
  • TICLOPIDINE HYDROCHLORIDEInactive2008-12-30
  • HYDROXYZINE HYDROCHLORIDEInactive2008-10-06
  • METFORMIN HYDROCHLORIDE USPInactive2008-02-01
  • NIMESULIDEInactive2007-08-28
  • LORATADINEInactive2007-04-30
  • TERBINAFINE HYDROCHLORIDEInactive2006-09-13
  • METOPROLOL SUCCINATEInactive2006-06-01

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to AARTI DRUGS LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

2 FDA enforcement records linked to this company.

  • warning_letter2013-08-02

    FDA Warning Letter (drug product)

  • warning_letter2013-08-02

    FDA Warning Letter (drug product)

For suppliers

Is this AARTI DRUGS LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.